These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 6390142)

  • 1. [Effect of metformin on glucose tolerance and insulin binding in semistarved obese women].
    Zancanaro C; Cigolini M; Bertoldi P; Mezzena G; Giacomoni P; Bosello O
    Minerva Endocrinol; 1984; 9(2):297-301. PubMed ID: 6390142
    [No Abstract]   [Full Text] [Related]  

  • 2. Beneficial effects of metformin in normoglycemic morbidly obese adolescents.
    Kay JP; Alemzadeh R; Langley G; D'Angelo L; Smith P; Holshouser S
    Metabolism; 2001 Dec; 50(12):1457-61. PubMed ID: 11735093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rosiglitazone is more effective than metformin in improving fasting indexes of glucose metabolism in severely obese, non-diabetic patients.
    Brunani A; Caumo A; Graci S; Castagna G; Viberti G; Liuzzi A
    Diabetes Obes Metab; 2008 Jun; 10(6):460-7. PubMed ID: 17394563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incretin hormone secretion in women with polycystic ovary syndrome: roles of obesity, insulin sensitivity, and treatment with metformin.
    Svendsen PF; Nilas L; Madsbad S; Holst JJ
    Metabolism; 2009 May; 58(5):586-93. PubMed ID: 19375579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of metformin on insulin-stimulated tyrosine kinase activity of erythrocytes from obese women with normal glucose tolerance.
    Santos RF; Nomizo R; Bopsco A; Wajchenberg BL; Reaven GM; Azhar S
    Diabetes Metab; 1997 Apr; 23(2):143-8. PubMed ID: 9137903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of metformin on insulin resistance in obese and hyperandrogenic women].
    Sir T; Castillo T; Muñoz S; López G; Calvillán M
    Rev Med Chil; 1997 Dec; 125(12):1457-63. PubMed ID: 9609021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparative evaluation of the effect of diet, pharmaco- and balneotherapy on a number of metabolic indices in obesity].
    Lukasheva MV; Mokina MN
    Vopr Kurortol Fizioter Lech Fiz Kult; 1982; (3):46-50. PubMed ID: 7113038
    [No Abstract]   [Full Text] [Related]  

  • 8. [The importance of the biguanides in the treatment of obesity].
    Bittnerová H; Masek J; Rath R
    Z Gesamte Inn Med; 1969 Mar; 24(5):139-42. PubMed ID: 5785830
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of lifestyle intervention and metformin on weight management and markers of metabolic syndrome in obese adolescents.
    Harden KA; Cowan PA; Velasquez-Mieyer P; Patton SB
    J Am Acad Nurse Pract; 2007 Jul; 19(7):368-77. PubMed ID: 17680902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Biguanides in treatment of obesity. II. Controlled clinical research with placebos, metformin and phenformin in obesity with normal and reduced tolerance to carbohydrates].
    Cucurachi L; Strata A; Zuliani U; Cucurachi P; Dell'Anna A
    Clin Ter; 1968 Nov; 47(3):233-45. PubMed ID: 4911791
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effect of a combined diet-training program on the insulin sensitivity of obese persons with normal or disordered glucose tolerance].
    Ratzmann KP; Zander E; Witt S; Schulz B
    Z Gesamte Inn Med; 1982 May; 37(10):304-8. PubMed ID: 7048770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metformin in the treatment of obesity in subjects with normal glucose tolerance.
    Tankova T; Dakovska L; Kirilov G; Koev D
    Rom J Intern Med; 2003; 41(3):269-75. PubMed ID: 15526510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Moxonidine improves glycaemic control in mildly hypertensive, overweight patients: a comparison with metformin.
    Chazova I; Almazov VA; Shlyakhto E
    Diabetes Obes Metab; 2006 Jul; 8(4):456-65. PubMed ID: 16776753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of metformin in obese and non-obese women with polycystic ovary syndrome: a randomized, double-blinded, placebo-controlled cross-over trial.
    Trolle B; Flyvbjerg A; Kesmodel U; Lauszus FF
    Hum Reprod; 2007 Nov; 22(11):2967-73. PubMed ID: 17766923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of hypocaloric diet plus sibutramine treatment on hormonal and metabolic features in overweight and obese women with polycystic ovary syndrome: a randomized, 24-week study.
    Florakis D; Diamanti-Kandarakis E; Katsikis I; Nassis GP; Karkanaki A; Georgopoulos N; Panidis D
    Int J Obes (Lond); 2008 Apr; 32(4):692-9. PubMed ID: 18071341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin sensitizing drugs increase the endogenous dopaminergic tone in obese insulin-resistant women with polycystic ovary syndrome.
    Ortega-González C; Cardoza L; Coutiño B; Hidalgo R; Arteaga-Troncoso G; Parra A
    J Endocrinol; 2005 Jan; 184(1):233-9. PubMed ID: 15642799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive value of glucose-insulin ratio in PCOS and profile of women who will benefit from metformin therapy: obese, lean, hyper or normoinsulinemic?
    Onalan G; Goktolga U; Ceyhan T; Bagis T; Onalan R; Pabuçcu R
    Eur J Obstet Gynecol Reprod Biol; 2005 Dec; 123(2):204-11. PubMed ID: 16316811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of metformin and diet on plasma testosterone and leptin levels in obese men.
    Ozata M; Oktenli C; Bingol N; Ozdemir IC
    Obes Res; 2001 Nov; 9(11):662-7. PubMed ID: 11707532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Serum level of retinol-binding protein 4 in obese patients with insulin resistance and in patients with type 2 diabetes treated with metformin].
    Tajtáková M; Semanová Z; Ivancová G; Petrovicová J; Donicová V; Zemberová E
    Vnitr Lek; 2007 Sep; 53(9):960-3. PubMed ID: 18019665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An observational study of reduction of insulin resistance and prevention of development of type 2 diabetes mellitus in women with polycystic ovary syndrome treated with metformin and diet.
    Glueck CJ; Goldenberg N; Sieve L; Wang P
    Metabolism; 2008 Jul; 57(7):954-60. PubMed ID: 18555837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.